Global Vaccines & Vaccination Market Size, Status and Forecast 2018-2025

Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease.

The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccines; recently developed vaccines that are safer and more effective; better public awareness; technological advancements in molecular genetics domain; and the adoption of novel vaccine delivery mechanisms are primarily driving the growth of the global vaccination market. Moreover, the development of new therapeutic and prophylactic vaccines for combating HIV/AIDS, congenital abnormalities, malaria, SARS and cancer, as well as other fatal diseases is also contributing the market's growth.

In 2017, the global Vaccines & Vaccination market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global Vaccines & Vaccination status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Vaccines & Vaccination development in United States, Europe and China.

The key players covered in this study

Abbott

AstraZeneca

Bavarian Nordic

Novartis

Bharat Biotech

Bio-Med

CSL

Emergent BioSolutions

GSK

Johnson & Johnson

Pfizer

Merck

Sanofi

Market segment by Type, the product can be split into

Subunit vaccines

Live attenuated vaccines

Conjugate vaccines

Inactivated vaccines

Recombinant vector vaccines

Toxoid vaccines

Synthetic vaccines

Dendritic cell vaccines

Market segment by Application, split into

Pediatrics disease market

Global adults disease

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Vaccines & Vaccination status, future forecast, growth opportunity, key market and key players.

To present the Vaccines & Vaccination development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Vaccines & Vaccination are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Vaccines & Vaccination Market Size Growth Rate by Type (2013-2025)
1.4.2 Subunit vaccines
1.4.3 Live attenuated vaccines
1.4.4 Conjugate vaccines
1.4.5 Inactivated vaccines
1.4.6 Recombinant vector vaccines
1.4.7 Toxoid vaccines
1.4.8 Synthetic vaccines
1.4.9 Dendritic cell vaccines
1.5 Market by Application
1.5.1 Global Vaccines & Vaccination Market Share by Application (2013-2025)
1.5.2 Pediatrics disease market
1.5.3 Global adults disease
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Vaccines & Vaccination Market Size
2.2 Vaccines & Vaccination Growth Trends by Regions
2.2.1 Vaccines & Vaccination Market Size by Regions (2013-2025)
2.2.2 Vaccines & Vaccination Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Vaccines & Vaccination Market Size by Manufacturers
3.1.1 Global Vaccines & Vaccination Revenue by Manufacturers (2013-2018)
3.1.2 Global Vaccines & Vaccination Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Vaccines & Vaccination Market Concentration Ratio (CR5 and HHI)
3.2 Vaccines & Vaccination Key Players Head office and Area Served
3.3 Key Players Vaccines & Vaccination Product/Solution/Service
3.4 Date of Enter into Vaccines & Vaccination Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Vaccines & Vaccination Market Size by Type (2013-2018)
4.2 Global Vaccines & Vaccination Market Size by Application (2013-2018)

5 United States
5.1 United States Vaccines & Vaccination Market Size (2013-2018)
5.2 Vaccines & Vaccination Key Players in United States
5.3 United States Vaccines & Vaccination Market Size by Type
5.4 United States Vaccines & Vaccination Market Size by Application

6 Europe
6.1 Europe Vaccines & Vaccination Market Size (2013-2018)
6.2 Vaccines & Vaccination Key Players in Europe
6.3 Europe Vaccines & Vaccination Market Size by Type
6.4 Europe Vaccines & Vaccination Market Size by Application

7 China
7.1 China Vaccines & Vaccination Market Size (2013-2018)
7.2 Vaccines & Vaccination Key Players in China
7.3 China Vaccines & Vaccination Market Size by Type
7.4 China Vaccines & Vaccination Market Size by Application

8 Japan
8.1 Japan Vaccines & Vaccination Market Size (2013-2018)
8.2 Vaccines & Vaccination Key Players in Japan
8.3 Japan Vaccines & Vaccination Market Size by Type
8.4 Japan Vaccines & Vaccination Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Vaccines & Vaccination Market Size (2013-2018)
9.2 Vaccines & Vaccination Key Players in Southeast Asia
9.3 Southeast Asia Vaccines & Vaccination Market Size by Type
9.4 Southeast Asia Vaccines & Vaccination Market Size by Application

10 India
10.1 India Vaccines & Vaccination Market Size (2013-2018)
10.2 Vaccines & Vaccination Key Players in India
10.3 India Vaccines & Vaccination Market Size by Type
10.4 India Vaccines & Vaccination Market Size by Application

11 Central & South America
11.1 Central & South America Vaccines & Vaccination Market Size (2013-2018)
11.2 Vaccines & Vaccination Key Players in Central & South America
11.3 Central & South America Vaccines & Vaccination Market Size by Type
11.4 Central & South America Vaccines & Vaccination Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Vaccines & Vaccination Introduction
12.1.4 Abbott Revenue in Vaccines & Vaccination Business (2013-2018)
12.1.5 Abbott Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Company Details
12.2.2 Company Description and Business Overview
12.2.3 Vaccines & Vaccination Introduction
12.2.4 AstraZeneca Revenue in Vaccines & Vaccination Business (2013-2018)
12.2.5 AstraZeneca Recent Development
12.3 Bavarian Nordic
12.3.1 Bavarian Nordic Company Details
12.3.2 Company Description and Business Overview
12.3.3 Vaccines & Vaccination Introduction
12.3.4 Bavarian Nordic Revenue in Vaccines & Vaccination Business (2013-2018)
12.3.5 Bavarian Nordic Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Vaccines & Vaccination Introduction
12.4.4 Novartis Revenue in Vaccines & Vaccination Business (2013-2018)
12.4.5 Novartis Recent Development
12.5 Bharat Biotech
12.5.1 Bharat Biotech Company Details
12.5.2 Company Description and Business Overview
12.5.3 Vaccines & Vaccination Introduction
12.5.4 Bharat Biotech Revenue in Vaccines & Vaccination Business (2013-2018)
12.5.5 Bharat Biotech Recent Development
12.6 Bio-Med
12.6.1 Bio-Med Company Details
12.6.2 Company Description and Business Overview
12.6.3 Vaccines & Vaccination Introduction
12.6.4 Bio-Med Revenue in Vaccines & Vaccination Business (2013-2018)
12.6.5 Bio-Med Recent Development
12.7 CSL
12.7.1 CSL Company Details
12.7.2 Company Description and Business Overview
12.7.3 Vaccines & Vaccination Introduction
12.7.4 CSL Revenue in Vaccines & Vaccination Business (2013-2018)
12.7.5 CSL Recent Development
12.8 Emergent BioSolutions
12.8.1 Emergent BioSolutions Company Details
12.8.2 Company Description and Business Overview
12.8.3 Vaccines & Vaccination Introduction
12.8.4 Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2013-2018)
12.8.5 Emergent BioSolutions Recent Development
12.9 GSK
12.9.1 GSK Company Details
12.9.2 Company Description and Business Overview
12.9.3 Vaccines & Vaccination Introduction
12.9.4 GSK Revenue in Vaccines & Vaccination Business (2013-2018)
12.9.5 GSK Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Company Details
12.10.2 Company Description and Business Overview
12.10.3 Vaccines & Vaccination Introduction
12.10.4 Johnson & Johnson Revenue in Vaccines & Vaccination Business (2013-2018)
12.10.5 Johnson & Johnson Recent Development
12.11 Pfizer
12.12 Merck
12.13 Sanofi

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Please Select Format

Single User: US $3900

Enterprise User: US $7800

Enquiry About Report

Need More Information

SIMILAR MARKET STUDIES

3D Bioprinting Market Size study, by Technology (syringe/extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting and other technologies) Component (3D Bioprinters, biomaterials and scaffolds) Application (drug testing and development, regenerative medicine, food testing, research and others) and Regional Forecasts 2018 - 2025

Global 3D Bioprinting Market valued approximately USD 307.6 million in 2017 is anticipated to reach USD 1,875.9 million by 2025 with a healthy growth rate of 25.36 % over the forecast period 2018-2025.

February 2019 | $3950 |View Details>>

Polyglycolic Acid Suture - Global Market Research and Forecast, 2015-2025

Summary The Polyglycolic Acid Suture report provides an independent information about the Polyglycolic Acid Suture industry supported by extensive research on factors such as industry segments size & trends, inhibitors, dynamics, drivers, opportunities & challenges, environment & policy, cost overview, porter�s five force analysis, and key companies profiles including business ...

February 2019 | $2200 |View Details>>

POC Glycated Hemoglobin Analyzer - Global Market Research and Forecast, 2015-2025

Summary The POC Glycated Hemoglobin Analyzer report provides an independent information about the POC Glycated Hemoglobin Analyzer industry supported by extensive research on factors such as industry segments size & trends, inhibitors, dynamics, drivers, opportunities & challenges, environment & policy, cost overview, porter�s five force analysis, and key companies profiles ...

February 2019 | $2200 |View Details>>

Pneumonia Vaccine - Global Market Research and Forecast, 2015-2025

Summary The Pneumonia Vaccine report provides an independent information about the Pneumonia Vaccine industry supported by extensive research on factors such as industry segments size & trends, inhibitors, dynamics, drivers, opportunities & challenges, environment & policy, cost overview, porter�s five force analysis, and key companies profiles including business overview and ...

February 2019 | $2200 |View Details>>

UPCOMING MARKET RESEARCH REPORTS

World Anesthesia Monitoring Devices Market - Opportunities and Forecasts, 2014 - 2020

Anesthesia can be monitored depending on the types of cases performed for the purpose of continuous assessment of the patients by measuring parameters such as patients oxygenation, circulation, ventilation, and temperature. It is logical that other clinical observations be supplemented to different monitoring devices.